Journal of Pharmacy and Pharmaceutical Sciences

Papers
(The H4-Index of Journal of Pharmacy and Pharmaceutical Sciences is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Evaluating the Effects of Agomelatine on Polysomnography Parameters in Patients with Obstructive Sleep Apnea.95
Therapeutic update on oral potassium exchange resin use in chronic kidney disease patients: a systematic review of randomized controlled clinical trials72
Effect of Oregon grape root extracts on P-glycoprotein mediated transport in in vitro cell lines70
The need to redefine diabetic cardiomyopathy as a unique clinical entity that requires pharmacotherapy29
Comparing broad and narrow phenotype algorithms: differences in performance characteristics and immortal time incurred29
Corrigendum: Applications of exhaled breath condensate analysis for drug monitoring and bioequivalence study of inhaled drugs27
Monkeypox: Virology, Pathophysiology, Clinical Characteristics, Epidemiology, Vaccines, Diagnosis, and Treatments25
Drug-disease interaction: Clinical consequences of inflammation on drugs action and disposition24
Effect of Concomitant Drug Use on the Onset and Exacerbation of Diabetes Mellitus in Everolimus-Treated Cancer23
Applications of Exhaled Breath Condensate Analysis for Drug Monitoring and Bioequivalence Study of Inhaled Drugs21
Network pharmacology and molecular docking reveal the immunomodulatory mechanism of rhubarb peony decoction for the treatment of ulcerative colitis and irritable bowel syndrome20
Pharmacological increases in circulating ketones fail to alleviate the hypertrophic cardiomyopathy present in the Tafazzin knockdown mouse model of Barth syndrome18
Post-Marketing Safety of Vemurafenib: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System17
Forkhead box O1 transcription factor; a therapeutic target for diabetic cardiomyopathy15
From fasting to fat reshaping: exploring the molecular pathways of intermittent fasting-induced adipose tissue remodeling15
Expanding the eligibility criteria for drugs in Canada’s time-limited health technology assessment and temporary drug access processes will further accelerate access to new medicines15
Effects of dual therapy with betamethasone and tetracycline in a NC/Nga mouse model of atopic dermatitis15
0.33890390396118